Etiracetam: Difference between revisions

Revision as of 19:46, 29 July 2010 editPotatoBot (talk \| contribs)Bots51,239 editsm Stub sorting and placement of stub template(s): nervous-system-drug-stub← Previous edit		Revision as of 18:20, 23 August 2010 edit undoChemNerd (talk \| contribs)Extended confirmed users17,568 editsNo edit summaryNext edit →
Line 1:		Line 1:
	{{Unreferenced stub\|auto=yes\|date=December 2009}}		{{Unreferenced stub\|auto=yes\|date=December 2009}}
	{{Drugbox\|		{{Drugbox\|
			\| drug_name = Etiracetam
	\|IUPAC_name = (''RS'')-''2-(2-oxopyrrolidin-1-yl)butanamide''		\|IUPAC_name = (''RS'')-''2-(2-oxopyrrolidin-1-yl)butanamide''
	\| image = Etiracetam structure.svg		\| image = Etiracetam structure.svg

Revision as of 18:20, 23 August 2010

This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Etiracetam" – news · newspapers · books · scholar · JSTOR (December 2009) (Learn how and when to remove this message)

Pharmaceutical compound

Etiracetam
Clinical data


Routes of administration	Oral
ATC code	none
Legal status
Legal status	Unscheduled (US)
Identifiers
IUPAC name (RS)-2-(2-oxopyrrolidin-1-yl)butanamide
CAS Number	33996-58-6
PubChem CID	59708
CompTox Dashboard (EPA)	DTXSID5046510
ECHA InfoCard	100.111.445
Chemical and physical data
Formula	C₈H₁₄N₂O₂
Molar mass	170.209 g/mol g·mol
3D model (JSmol)	Interactive image
SMILES CCC(C(=O)N)N1CCCC1=O

Etiracetam is a nootropic drug of the racetam family. It is racemic; its biologically active enantiomeric form is levetiracetam.